Dr. Miver Erem Tokuş
NeurosurgeryVerified
- 24+years exp.
English · Turkish
FromPrice on request
Free quote
60 seconds · no obligationView Profile
Functional Neurosurgery
Mr-guided focused ultrasound (mrgfus)
What MR-guided focused ultrasound (MRgFUS) is, how MRI-guided acoustic energy treats essential tremor and Parkinson's without surgical incisions, what clinical evidence shows, who qualifies based on skull density, approximate costs in Turkey compared with the UK, US and Germany, what before-and-after results look like, recovery milestones, potential risks and how to choose an experienced neurosurgical team.
A written plan with the surgeon's name and the full price — usually within 24 hours.
- Category
- Functional Neurosurgery
- Hospitals
- 2
- Verified
- 1
- Price from
- Price on request
Verified surgeons for MR-Guided Focused Ultrasound (MRgFUS)
1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.
MR-guided focused ultrasound (MRgFUS) in Turkey: what it is and how it works
MR-guided focused ultrasound (MRgFUS) is an incisionless neurosurgical procedure designed to treat disabling movement disorders, particularly medication-refractory essential tremor and tremor-dominant Parkinson's disease. Unlike conventional brain surgery, it requires no incisions, no burr holes, and no implanted hardware. Instead, more than a thousand ultrasound beams pass safely through the intact skull, converging at a single focal point deep within the brain to create a precise thermal lesion that silences tremor-causing circuits.
Magnetic resonance imaging (MRI) guides the entire intervention. The scanner provides high-resolution anatomical maps and continuous thermal measurements in real time, allowing the team to verify tremor relief before making a permanent lesion. Turkish neurosurgical centres offer this treatment for patients seeking an effective non-invasive alternative to open surgery; see our overview of neurosurgery treatments in Turkey.
How acoustic energy crosses the skull: the technical mechanism
The mechanism relies on acoustic physics and real-time MR thermometry. The patient lies in an MRI scanner wearing a specialised helmet containing over one thousand ultrasound transducers. Chilled, degassed water circulates between the helmet and the scalp to protect the skull from heating. Each ultrasound beam passes independently through bone and tissue without causing damage, but where all beams converge—at a target measuring only a few millimetres across—their combined energy generates concentrated thermal coagulation.
Throughout the session, the MRI scanner tracks tissue temperature within sub-millimetre margins. The neurosurgeon first delivers low-power test sonications to warm the target to 40–45°C. This temporary warming allows the neurologist to test tremor suppression and check for unwanted sensations while the patient is awake. Once accuracy is verified, therapeutic sonications heat the focal point to 55–60°C for roughly ten to twenty seconds, permanently disrupting the tremor pathway.
Does MR-guided focused ultrasound (MRgFUS) actually work? What the evidence says
Clinical trials and regulatory bodies confirm that MR-guided focused ultrasound provides substantial, immediate, and durable tremor reduction. Both the US Food and Drug Administration (FDA) and the UK National Institute for Health and Care Excellence (NICE) approve MRgFUS for essential tremor and tremor-dominant Parkinson's disease. International clinical studies show that treated patients experience an average 70% to 80% reduction in dominant hand tremor, with functional improvements sustained across several years.
However, the evidence is subject to clear clinical boundaries. MRgFUS is approved and routinely performed as a unilateral procedure to treat the dominant hand; bilateral treatments carry higher risks of speech and swallowing complications. Furthermore, while the technique reliably dampens physical tremors, it does not cure underlying neurodegenerative conditions such as Parkinson's disease, nor does it halt disease progression or relieve non-motor symptoms such as cognitive changes or balance instability.
MR-guided focused ultrasound (MRgFUS) cost in Turkey compared with the UK, US and Germany
The table below provides approximate cost ranges for unilateral MR-guided focused ultrasound. Because the treatment requires high-field MRI suites, specialised transducer apparatus, and an expert multidisciplinary team, prices reflect advanced clinical overheads. Individual quotes depend on pre-operative scans and hospital stay duration.
| Country | Approximate cost range |
|---|---|
| Turkey | €15,000 – €28,000 |
| United Kingdom | €22,000 – €38,000 |
| United States | €35,000 – €65,000 |
| Germany | €25,000 – €45,000 |
Price differences stem mainly from hospital operating expenses and regional medical service costs. In Turkey, competitive rates include comprehensive international patient packages: pre-procedure MRI and CT imaging, the full MRgFUS session, overnight hospitalisation, nursing care, post-procedure evaluations, and airport transfers. Request a full written cost breakdown before confirming your travel dates.
MRgFUS, deep brain stimulation (DBS) or stereotactic radiosurgery?
Patients with severe tremor typically weigh three primary interventions: MRgFUS, Deep Brain Stimulation (DBS), and Stereotactic Radiosurgery (Gamma Knife). Each method has distinct indications, advantages, and limitations.
| Treatment approach | Best suited to | Typical limits |
|---|---|---|
| MR-guided focused ultrasound (MRgFUS) | Medication-refractory essential tremor or tremor-dominant Parkinson's seeking incisionless care | Unilateral treatment; requires sufficient skull density ratio (SDR); non-reversible lesion |
| Deep Brain Stimulation (DBS) | Bilateral tremor, motor fluctuations, dystonia, or younger patients wanting adjustable therapy | Invasive craniotomy, burr holes, implanted hardware, infection risk, battery maintenance |
| Stereotactic Radiosurgery (Gamma Knife) | Patients unsuitable for frame or MRI who prefer single-session radiation | Delayed therapeutic response over months; lack of intraoperative real-time feedback |
MRgFUS is incisionless and eliminates the hardware complications, infection risks, and maintenance visits associated with DBS. Conversely, DBS can treat both sides of the body and remains adjustable. Stereotactic radiosurgery avoids incisions but takes months to demonstrate clinical effects without real-time feedback. Similar high-precision diagnostic imaging and neurosurgical planning are employed in other functional treatments, such as the surgical treatment of epilepsy.
Who is an eligible candidate, and who is not?
Suitable candidates are adults with a confirmed diagnosis of essential tremor or tremor-dominant Parkinson's disease that severely disrupts everyday tasks such as eating, writing, and dressing, and has failed to respond to standard medications. Candidates must be able to lie comfortably flat inside an MRI scanner for over two hours while remaining alert and responsive to commands.
A critical determinant of eligibility is the skull density ratio (SDR), assessed using a pre-operative thin-slice CT scan. If the skull bone is too dense or porous, ultrasound waves scatter, heating the skull rather than reaching the target. Patients with an SDR below 0.40 are usually ineligible. Other contraindications include non-MRI-conditional pacemakers or metallic implants, severe claustrophobia, extensive systemic illness, and unrealistic expectations regarding untreated limbs.
What happens on treatment day: the step-by-step procedure
The MRgFUS procedure follows a rigorous step-by-step clinical protocol:
- Scalp preparation: The patient's head is shaved completely smooth. Hair traps tiny air bubbles that disperse ultrasound beams and increase scalp heating.
- Frame attachment: A lightweight stereotactic head frame is secured using local anaesthetic at four contact points to prevent motion during scanning.
- Scanner positioning: The patient lies on the MRI bed with their head inside the water-cooled transducer helmet, sealed with a silicone membrane.
- Targeting and testing: High-resolution MRI identifies the ventral intermediate nucleus (VIM). Low-power test sonications allow the neurologist to assess tremor reduction and confirm absence of side effects while the patient draws spirals or holds a cup.
- Thermal ablation: High-energy sonications heat the focal spot to 55–60°C for ten to twenty seconds, permanently creating the therapeutic lesion.
- Completion: Final MRI scans confirm lesion positioning. The frame is removed, pin sites are dressed, and the patient rests. The entire process takes approximately two to three hours.
MR-guided focused ultrasound (MRgFUS) before and after: realistic tremor changes
Tremor relief after MRgFUS is immediate. Patients frequently observe substantial reductions in hand shaking while still on the scanner table, often completing handwriting tests or drinking from a glass without assistance minutes after the final sonication. Functional before-and-after evaluations document restored independence in daily activities such as eating with cutlery, using keys, and writing legibly.
However, understanding realistic expectations is vital. Clinical photographs and video assessments show dramatic improvement in the treated arm, but the untreated limb remains unchanged. In addition, roughly 10% to 15% of patients note a minor return of tremor over subsequent months as post-procedure brain edema resolves around the lesion margin. While functional gains remain substantial for the vast majority, MRgFUS does not provide a universal or disease-halting cure.
Your medical trip to Turkey and recovery timeline
Patients travelling to Turkey for MRgFUS typically stay four to six nights. This timeframe accommodates pre-operative CT and MRI evaluations, the treatment session, an overnight hospital stay, and a follow-up neurological review before departure. Recovery proceeds through defined phases:
- Days 1–2 (Arrival & procedure): Clinical consultation and imaging occur on day one. Treatment takes place on day two, followed by an overnight hospital stay for observation.
- Days 3–5 (Discharge & recovery): Most patients leave the hospital on day three, resting at their hotel. A follow-up examination confirms neurological stability before flying home.
- Weeks 1–4 (Resuming routine): Normal domestic tasks and desk work typically resume within seven to ten days. Mild transient balance changes or tiredness generally resolve by week four.
Learn more about travel arrangements and hospital coordination in our guide to neurosurgery treatments in Turkey.
Potential risks, complications and neurological side effects
Although MRgFUS avoids incisions, craniotomy, and general anaesthesia, it creates a permanent lesion within brain tissue and carries specific risks. Data from regulatory bodies such as NICE and the FDA indicate that adverse events are predominantly mild to moderate and temporary.
Common transient effects include numbness or tingling in the fingers or lips (paresthesia), mild imbalance or unsteady gait (ataxia), dizziness during sonications, and scalp tenderness from frame pins. In clinical studies, these transient symptoms affect roughly 15% to 35% of patients and usually resolve within two to eight weeks as post-treatment swelling subsides. Permanent complications, such as persistent numbness or lasting speech alterations (dysarthria), are uncommon, occurring in approximately 2% to 5% of cases. A thorough consultation ensures you understand these statistical probabilities before proceeding.
How to choose a neurosurgical centre and essential questions to ask
Choosing an accredited hospital with an established movement disorders programme is critical. The neurosurgical centre should feature a dedicated team consisting of a functional neurosurgeon, a movement disorder neurologist, and an experienced MR physicist. The facility must possess modern 3-Tesla MRI suites configured for focused ultrasound and on-site neuro-intensive care.
Red flags include clinics that quote prices without reviewing a recent thin-slice CT scan, guarantee complete tremor cure, or offer simultaneous bilateral treatment. Before scheduling, ask the clinical team these essential questions:
- How many MRgFUS procedures has your team completed for essential tremor or Parkinson's?
- What is my skull density ratio (SDR), and does it support safe thermal heating?
- Who performs my intraoperative neurological assessments during the sonications?
- What follow-up support is provided once I return to my home country?
To learn how we connect patients with accredited neurosurgical departments, read how it works and request a personalised assessment through our free quote service.
Hospitals with Neurosurgery in Turkey
Frequently asked questions
MR-guided focused ultrasound (MRgFUS) is an incisionless neurosurgical procedure that treats movement disorders like essential tremor and tremor-dominant Parkinson's disease. Using high-field MRI guidance, over a thousand ultrasound beams converge through the intact skull to create a precise thermal lesion in the brain's thalamus, interrupting abnormal tremor signals without surgical cuts or implants.
Yes. Clinical trials and international regulatory approvals by NICE and the FDA confirm that MRgFUS substantially reduces tremors. On average, patients experience a 70% to 80% reduction in dominant hand tremor immediately after treatment. However, it treats one side, does not cure underlying neurodegeneration, and does not stop the overall progression of Parkinson's disease.
In Turkey, MRgFUS typically costs between €15,000 and €28,000, compared with €22,000 to €38,000 in the UK and up to €65,000 in the US. Comprehensive Turkish hospital packages generally include pre-procedure MRI and CT imaging, the ultrasound procedure, intraoperative monitoring, one night of hospital admission, nursing care, and local airport transfers.
Tremor reduction in the treated hand is immediate and noticeable during the procedure. Patients who previously struggled with severe shaking can often write legibly, use cutlery, and drink from an open cup without spilling right away. However, the untreated hand is not affected, and mild tremor recurrence can occur in some individuals as swelling subsides.
MRgFUS is non-invasive, requiring no incisions, burr holes, or implanted hardware, which eliminates risks of device infection and battery replacements. However, MRgFUS creates a permanent, non-reversible lesion and is standardly unilateral. DBS is surgically invasive but can treat both sides of the body, remains adjustable, and is reversible should newer therapies emerge.
Recovery is relatively rapid because there are no surgical wounds. Most patients spend one night in the hospital for observation and return to their hotel the following morning. Light domestic activities and desk work can usually resume within seven to ten days. Temporary balance unsteadiness or mild fatigue typically resolves within two to four weeks.
The procedure is not considered painful, though it involves brief discomfort. Local anaesthetic numbs the four frame pin sites on the scalp. During sonications, patients may feel warmth, pressure, or brief dizziness lasting ten to twenty seconds. Chilled water circulating around the scalp prevents overheating, and pain medication is provided if a mild headache develops afterwards.
Long-term clinical follow-up studies demonstrate that tremor reduction achieved through MRgFUS remains durable across three to five years and beyond for the majority of patients. While a small percentage of individuals experience minor tremor recurrence as post-treatment tissue edema settles during the first year, substantial functional improvement in daily living typically persists.
MRgFUS is considered safe and is approved by regulatory authorities including NICE and the FDA. Because it requires no incisions or general anaesthesia, surgical infection and haemorrhage risks are minimal. The most common side effects—mild numbness, tingling, or temporary balance unsteadiness—usually resolve within weeks. Permanent neurological deficits occur in approximately 2% to 5% of cases.
Most patients stay in Turkey for four to six nights. This provides sufficient time for pre-treatment consultations, thin-slice CT skull density confirmation, the procedure itself, one overnight hospital admission, and a comprehensive follow-up neurological assessment. Once the treating neurosurgeon confirms your post-treatment stability, you are cleared for your return flight home.
Patient stories